Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $1.51 Million - $1.83 Million
-9,200 Reduced 21.85%
32,900 $6.5 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $3.53 Million - $4.12 Million
22,800 Added 118.13%
42,100 $7.22 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $447,496 - $509,880
2,800 Added 16.97%
19,300 $3.51 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $1.38 Million - $1.55 Million
10,000 Added 153.85%
16,500 $2.56 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $587,796 - $680,460
4,400 Added 209.52%
6,500 $968,000
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $278,271 - $346,290
2,100 New
2,100 $282,000
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $1.37 Million - $1.64 Million
-9,900 Reduced 24.63%
30,300 $4.9 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $5.4 Million - $6.19 Million
40,200 New
40,200 $5.4 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $1.03 Million - $1.28 Million
7,800 Added 20.16%
46,500 $7.54 Million
Q4 2021

May 03, 2022

BUY
$107.43 - $135.93 $1.46 Million - $1.85 Million
13,600 Added 54.18%
38,700 $5.24 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $25.1 Million - $31.8 Million
-234,100 Reduced 90.32%
25,100 $3.4 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $901,488 - $1.22 Million
-11,200 Reduced 4.14%
259,200 $27.8 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $13.1 Million - $15.4 Million
-152,900 Reduced 36.12%
270,400 $23.7 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $9.62 Million - $12.9 Million
-131,100 Reduced 23.65%
423,300 $41.6 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $2.9 Million - $4.4 Million
45,000 Added 8.83%
554,400 $42.2 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $8.81 Million - $11 Million
-122,100 Reduced 19.33%
509,400 $44.5 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $4.93 Million - $5.93 Million
78,300 Added 14.15%
631,500 $47.1 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $36.3 Million - $46.5 Million
553,200 New
553,200 $40.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.